Novartis

Novartis AG is a global leader in the pharmaceutical and healthcare industry, headquartered in Basel, Switzerland. As one of the largest pharmaceutical companies in the world, Novartis consistently ranks among the top five in the industry, with its innovative medicines and therapies impacting millions of lives worldwide. In 2022, it was the fourth-largest pharmaceutical company by revenue, underscoring its significant role in advancing global healthcare.

Novartis operates across two primary business segments: Innovative Medicines and Sandoz. The Innovative Medicines division focuses on developing cutting-edge treatments for a wide range of diseases, including cardiovascular conditions, cancer, neurological disorders, and rare diseases. The company invests heavily in research and development (R&D), leveraging advanced technologies such as gene therapy, digital health, and artificial intelligence to drive innovation and improve patient outcomes. Its portfolio includes breakthrough therapies like Cosentyx, Entresto, and Zolgensma, which have transformed treatment paradigms in their respective fields.

Sandoz, the generics and biosimilars division of Novartis, plays a critical role in making high-quality, affordable medicines accessible to patients worldwide. By producing generic versions of off-patent drugs and biosimilars, Sandoz helps reduce healthcare costs and expands access to essential treatments.

Novartis is also committed to sustainability and social responsibility. The company focuses on improving global health equity, reducing its environmental footprint, and fostering ethical business practices. Through initiatives like the Novartis Access program, it provides affordable medicines to low- and middle-income countries, addressing critical healthcare gaps.

With a strong emphasis on innovation, patient-centricity, and sustainability, Novartis continues to shape the future of healthcare. Its dedication to improving lives and addressing unmet medical needs solidifies its position as a trusted leader in the pharmaceutical industry, driving progress and delivering value to patients, healthcare systems, and society at large.